MaravirocstrokeSwissmedicGeneva Competent Ethics CommitteeSwiss Agency for Therapeutic ProductsNCT07080567standard rehabilitation therapy
…aim is to assess the efficacy and safety of the CCR5 antagonist Maraviroc for improving motor recovery of the upper limb after ischaemic …